These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 3677422

  • 1. Determination of erythrocyte porphobilinogen deaminase activity using porphobilinogen as substrate.
    Hsiao KJ, Lee FY, Wu SJ, Chang WJ.
    Clin Chim Acta; 1987 Sep 30; 168(2):257-8. PubMed ID: 3677422
    [No Abstract] [Full Text] [Related]

  • 2. Assay for erythrocyte uroporphyrinogen I synthase activity, with porphobilinogen as substrate.
    Ford RE, Ou CN, Ellefson RD.
    Clin Chem; 1980 Jul 30; 26(8):1182-5. PubMed ID: 7389090
    [Abstract] [Full Text] [Related]

  • 3. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria.
    Kostrzewska E, Gregor A.
    Ann Clin Res; 1986 Jul 30; 18(4):195-8. PubMed ID: 3789651
    [Abstract] [Full Text] [Related]

  • 4. Studies on erythrocyte porphobilinogen deaminase and uroporphyrinogen cosynthetase in porphyria cutanea tarda.
    Blekkenhorst GH, Day RS, Eales L.
    Int J Biochem; 1981 Jul 30; 13(8):963-6. PubMed ID: 7053226
    [No Abstract] [Full Text] [Related]

  • 5. Lack of effect of pregnancy or hematin therapy on erythrocyte porphobilinogen deaminase activity in acute intermittent porphyria.
    Sassa S, Kappas A.
    N Engl J Med; 1989 Jul 20; 321(3):192-3. PubMed ID: 2747754
    [No Abstract] [Full Text] [Related]

  • 6. Erythrocyte porphobilinogen deaminase activity in liver diseases and proliferative diseases of the haemopoietic system and lymph nodes.
    Ostrowski J, Lutyński A, Cianciara J, Martyńska M, Kostrzewska E, Butruk E.
    Mater Med Pol; 1987 Jul 20; 19(4):234-7. PubMed ID: 3454831
    [No Abstract] [Full Text] [Related]

  • 7. Normal erythrocyte uroporphyrinogen I synthase in a kindred with acute intermittent porphyria.
    Mustajoki P.
    Ann Intern Med; 1981 Aug 20; 95(2):162-6. PubMed ID: 7258864
    [Abstract] [Full Text] [Related]

  • 8. ELISA for measuring porphobilinogen deaminase in human erythrocytes.
    Lannfelt L, Wetterberg L, Lilius L, Thunell S, Gellerfors P.
    Clin Chim Acta; 1989 Aug 15; 183(2):227-37. PubMed ID: 2791307
    [Abstract] [Full Text] [Related]

  • 9. Is porphobilinogen deaminase activity a secondary control mechanism in haem biosynthesis in humans? [proceedings].
    Brodie MJ, Moore MR, Thompson GG, Campbell BC, Goldberg A.
    Biochem Soc Trans; 1977 Aug 15; 5(5):1466-8. PubMed ID: 923960
    [No Abstract] [Full Text] [Related]

  • 10. Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity.
    Herrick AL, McColl KE, Moore MR, Brodie MJ, Adamson AR, Goldberg A.
    Br J Clin Pharmacol; 1989 Apr 15; 27(4):491-7. PubMed ID: 2497768
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of the diagnostic usefulness of determining porphobilinogen deaminase activity in the erythrocytes in patients with acute intermittent porphyria and in carriers of the gene of this type of porphyria].
    Gregor A, Kocyłowski M, Kostrzewska E.
    Przegl Lek; 1986 Apr 15; 43(11):703-5. PubMed ID: 3575772
    [No Abstract] [Full Text] [Related]

  • 12. Erythrocyte porphobilinogen deaminase activity in liver disease.
    Ostrowski J.
    Gastroenterology; 1987 Apr 15; 92(4):845-51. PubMed ID: 3556992
    [Abstract] [Full Text] [Related]

  • 13. Uroporphyrinogen-I-synthetase activity in red blood cells of lead-exposed workers.
    El-Waseef A.
    Acta Med Acad Sci Hung; 1982 Apr 15; 39(1-2):95-100. PubMed ID: 7180366
    [Abstract] [Full Text] [Related]

  • 14. Porphobilinogen deaminase and the synthesis of porphyrin isomers in the Dubin-Johnson syndrome.
    Cohen C, Kirsch RE, Moore MR.
    S Afr Med J; 1986 Jul 05; 70(1):36-9. PubMed ID: 3726684
    [Abstract] [Full Text] [Related]

  • 15. Purification of porphobilinogen deaminase from human erythrocytes by fast protein liquid chromatography.
    de Rooij FW, Hamer CM, Wilson JH.
    Clin Chim Acta; 1987 Jan 15; 162(1):61-8. PubMed ID: 3802547
    [Abstract] [Full Text] [Related]

  • 16. Porphyrin biosynthesis and enzymatic studies in erythrocytes from normals and porphyric humans.
    Parera VE, Stella AM, Wider de Xifra EA, Fukuda H, Batlle AM.
    Int J Biochem; 1980 Jan 15; 12(5-6):947-53. PubMed ID: 7450154
    [No Abstract] [Full Text] [Related]

  • 17. Red blood cell porphobilinogen deaminase in the evaluation of acute intermittent porphyria.
    Pierach CA, Weimer MK, Cardinal RA, Bossenmaier IC, Bloomer JR.
    JAMA; 1987 Jan 02; 257(1):60-1. PubMed ID: 3783903
    [Abstract] [Full Text] [Related]

  • 18. Immunological determination of porphobilinogen deaminase as a diagnostic measure in acute intermittent porphyria.
    Lannfelt L.
    J Clin Chem Clin Biochem; 1990 May 02; 28(5):273-8. PubMed ID: 2380662
    [Abstract] [Full Text] [Related]

  • 19. Increased erythrocyte uroporphyrinogen-l-synthetase, delta-aminolevulinic acid dehydratase and protoporphyrin in hemolytic anemias.
    Anderson KE, Sassa S, Peterson CM, Kappas A.
    Am J Med; 1977 Sep 02; 63(3):359-64. PubMed ID: 900140
    [No Abstract] [Full Text] [Related]

  • 20. Determination of erythrocyte hydroxymethylbilane synthase activity and its application for study of acute intermittent porphyria.
    Lee FY, Hsiao KJ, Tsai YT, Lee SD, Wu SJ, Jeng HS.
    Taiwan Yi Xue Hui Za Zhi; 1988 Nov 02; 87(11):1029-35. PubMed ID: 3235962
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.